Every year, roughly 287,000 women die from causes directly related to pregnancy or childbirth. This equals one death every two minutes. More than 94 percent of these deaths occur in low- and middle-income countries. Most happen from conditions that medicine has known how to treat for decades. The drugs exist. The procedures are straightforward. Therefore, understanding why most maternal deaths are preventable is a critical public health challenge. It is not a failure of medical knowledge. It is a catastrophic failure of healthcare delivery.
India accounts for approximately 17 percent of global maternal deaths. According to the World Health Organization, India’s maternal mortality ratio (MMR) fell significantly. It dropped from 254 per 100,000 live births in 2004 to 97 in the 2018-2020 period. The Janani Suraksha Yojana cash-incentive scheme drove much of this reduction. This progress is real. However, it conceals a massive internal divide. Kerala’s MMR stands at 19. Conversely, Assam’s sits at 195. Consequently, a woman’s survival odds depend entirely on her location.
Key Takeaways: Why Most Maternal Deaths Are Preventable
- Postpartum hemorrhage and pre-eclampsia cause most maternal deaths.
- Simple, affordable treatments like oxytocin and magnesium sulfate exist.
- Therefore, maternal deaths are preventable with basic healthcare delivery.
- Skilled birth attendance is the single most effective intervention.
- Uneven implementation leaves millions of women entirely unprotected.
What Actually Kills Women in Childbirth
Most maternal deaths trace back to a very short list of causes. These include severe postpartum bleeding, dangerously high blood pressure, blood infection after delivery, and unsafe abortion complications. Postpartum hemorrhage alone accounts for roughly 27 percent of maternal deaths in India. Imagine a tap that will not switch off. A uterus failing to contract can drain fatal blood volume within 30 minutes. Without oxytocin on the shelf, that window closes fast.
Pre-eclampsia and eclampsia are the second major cause. Magnesium sulfate prevents most eclamptic seizures from becoming fatal. It costs less than 100 rupees per dose. Its presence at a delivery facility means the difference between a managed complication and a preventable death.
Evidence Proving Maternal Deaths Are Preventable
In 2014, Bhutta et al. published critical findings in The Lancet. They estimated that universal coverage of evidence-based interventions could prevent up to 71 percent of maternal deaths globally. These interventions include oxytocin, magnesium sulfate, skilled birth attendance, and antenatal screening. The scientific frontier is not the problem. The problem is achieving consistent coverage.
Neighboring countries demonstrate this reality. Sri Lanka maintains an MMR below 30. Nepal reduced its MMR from above 900 in the 1990s to under 150 today. Both nations achieved this by scaling skilled birth attendance. They ensured 24-hour access to emergency obstetric care at primary facilities. They invested consistently in healthcare personnel, not just sophisticated buildings.
India’s own data reinforces this point. Research using NFHS-4 survey data linked institutional deliveries to substantially lower maternal mortality risk. The JSY scheme removed the cost barrier for government hospital delivery. Consequently, it contributed directly to the national MMR reduction.
Where the Delivery System Still Fails
The 71 percent prevention figure assumes universal coverage. India is simply not there. Fewer than 40 percent of Community Health Centers provide round-the-clock emergency obstetric care. Oxytocin stockouts remain documented and recurring at tier-2 and tier-3 facilities. The drug sits on the WHO Essential Medicines List. However, it is frequently unavailable when needed.
Human resources represent the second massive gap. India’s NHM Midwifery Initiative aims to deploy nurse-midwife practitioners. This model removes the physician bottleneck at small facilities. States moving fastest on midwifery deployment show early improvements in attendance rates. However, implementation across high-burden states remains deeply uneven.
District-level MMR data would expose the specific gaps that state averages hide. The Assam-Kerala disparity is obvious. The facility-level gaps within high-burden districts are not. Those specific facilities are exactly where preventable deaths concentrate. Bringing district-level reporting into the national framework would create necessary pressure for local action.
The facilities lacking nighttime coverage are identifiable. The oxytocin stockouts appear in surveys. The districts needing skilled attendance are listed in NFHS tables. Therefore, maternal mortality is not a research problem anymore. It is a last-mile delivery failure. We know precisely what needs to be done.
This article is for educational purposes only and does not constitute medical advice, diagnosis, or treatment recommendations. Consult a qualified healthcare provider for any health concerns. See our Medical Disclaimer.
Sources
- World Health Organization. Trends in Maternal Mortality 2000 to 2020. Geneva: WHO; 2023.
- Bhutta ZA, et al. Can available interventions end preventable deaths in mothers, newborn babies, and stillbirths? Lancet. 2014 Jul 26;384(9940):347-70. PMID: 24853604.
- Registrar General of India. Special Bulletin on Maternal Mortality in India 2018-20. Office of the Registrar General, India; 2022.
- Randive B, et al. India’s Conditional Cash Transfer Programme (the JSY) to promote institutional birth. PLoS One. 2013;8(6):e67452. PMID: 23840693.
Leave a Comment